HomeHealth

Health

Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report

Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report

September 8, 2017

ImmunoGen had an Impressive 12% Climb Today

ImmunoGen had an Impressive 12% Climb Today

August 30, 2017

The Market Empties On Otonomy Inc. Stock

The Market Empties On Otonomy Inc. Stock

August 30, 2017

Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval

Adamas Pharmaceuticals’ Stock Skyrockets After its Drug Gocovri Gain FDA Approval

August 25, 2017

Horizon Pharma Increased More Than 13% Today, Here’s Why

Horizon Pharma Increased More Than 13% Today, Here’s Why

August 17, 2017

Shares of Synergy Pharmaceuticals are Falling Today and This is Why

Shares of Synergy Pharmaceuticals are Falling Today and This is Why

August 10, 2017

Shares of Surgery Partners Plummeted Today and This is Why

Shares of Surgery Partners Plummeted Today and This is Why

August 9, 2017

Shares Slide After Endo International Lowers 2017 Revenue Forecast

Shares Slide After Endo International Lowers 2017 Revenue Forecast

August 8, 2017

Goldberg Law PC is Investigating Depomed, Inc.

Goldberg Law PC is Investigating Depomed, Inc.

August 8, 2017

The Man Who Spiked Up The Price of Daraprim, Martin Shkreli, Found Guilty of Three Counts of Securities Fraud

The Man Who Spiked Up The Price of Daraprim, Martin Shkreli, Found Guilty of Three Counts of Securities Fraud

August 4, 2017

« 1 … 149 150 151 152 153 … 155 »